Immuron's market cap is obscenely, and I mean it, obscenely low when you consider that we have a revenue generating product growing very quickly in Travelan that shows great efficacy and the DoD, Navy, and other U.S. defense agencies are testing, 3 advanced stage liver disease trials (two funded by NIH), and a very promising drug in Stage II for C.Diff.
Trial Results, page-17
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
-0.006(5.71%) |
Mkt cap ! $22.57M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.9¢ | $32.90K | 328.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27022 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| IMC (ASX) Chart |